These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26684547)

  • 1. Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.
    Freire MP; Pierrotti LC; Oshiro IC; Bonazzi PR; Oliveira LM; Machado AS; Van Der Heijden IM; Rossi F; Costa SF; D'Albuquerque LA; Abdala E
    Liver Transpl; 2016 May; 22(5):615-26. PubMed ID: 26684547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?
    Freire MP; Song ATW; Oshiro ICV; Andraus W; D'Albuquerque LAC; Abdala E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115220. PubMed ID: 33045498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients.
    Kim YJ; Kim SI; Lee YD; Choi HJ; Choi JY; Yoon SK; You YK; Kim DG
    Transplant Proc; 2018 May; 50(4):1132-1135. PubMed ID: 29731080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin use as a risk factor for colonization or infection with polymyxin-resistant Acinetobacter baumannii after liver transplantation.
    Freire MP; Van Der Heijden IM; do Prado GV; Cavalcante LS; Boszczowski I; Bonazzi PR; Rossi F; Guimarães T; D'Albuquerque LA; Costa SF; Abdala E
    Transpl Infect Dis; 2014 Jun; 16(3):369-78. PubMed ID: 24725123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.
    Freire MP; Oshiro IC; Pierrotti LC; Bonazzi PR; de Oliveira LM; Song AT; Camargo CH; van der Heijden IM; Rossi F; Costa SF; DʼAlbuquerque LA; Abdala E
    Transplantation; 2017 Apr; 101(4):811-820. PubMed ID: 28009779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation.
    Min EK; Yim SH; Choi MC; Lee JG; Joo DJ; Kim MS; Kim DG
    Clin Transplant; 2023 May; 37(5):e14956. PubMed ID: 36860160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation.
    Reddy P; Zembower TR; Ison MG; Baker TA; Stosor V
    Transpl Infect Dis; 2010 Feb; 12(1):87-93. PubMed ID: 19735384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?
    An JH; Kim YH; Moon JE; Jeong JH; Kim SH; Kang SJ; Park KH; Jung SI; Jang HC
    Am J Infect Control; 2017 Jun; 45(6):667-672. PubMed ID: 28242072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
    Henig O; Weber G; Hoshen MB; Paul M; German L; Neuberger A; Gluzman I; Berlin A; Shapira C; Balicer RD
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2063-8. PubMed ID: 26205665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients.
    Dadon Z; Ben-Chetrit E; Benjaminov O; Taha L; Wiener-Well Y; Belman D; Levin PD
    Clin Microbiol Infect; 2021 Apr; 27(4):635.e1-635.e4. PubMed ID: 33421579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.
    Latibeaudiere R; Rosa R; Laowansiri P; Arheart K; Namias N; Munoz-Price LS
    Clin Infect Dis; 2015 Feb; 60(3):415-22. PubMed ID: 25352586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.